Pharma Prescribed with Artem Adrianov, CEO & Founder of Cyntegrity; How to predict failure before it happens

I’m Adam Walker a Biometrics consultant, and this is the Pharma Prescribed Podcast—where leaders, innovators, and hidden voices in healthcare open up. No soundbites. No spin. Just raw insight—one prescription at a time. In an industry driven by data, protocols, and pressure, we rarely pause to ask the human questions: What drives us? What breaks us? And what truths live behind the titles we wear? Our guest today is Artem Adrianov. 🎙️ Spotlight: Dr. Artem Andrianov Mathematician. Strategist. Risk based quality mgt trailblazer. As co-founder and CEO of Cyntegrity, Dr. Artem Andrianov has spent over 25 years transforming clinical trials through data intelligence and risk-based methodologies. With a Ph.D. in Mathematical Modelling and an Executive MBA from Cass Business School, Artem blends scientific rigor with business acumen to make trials safer, smarter, and more efficient. Since launching Cyntegrity in 2013, he has led the development of platforms that optimize trial oversight, reduce monitoring costs, and elevate data quality. His work spans collaborations with big Pharma, and his expertise covers Spirometry, ECG, Oncology, ePROs, and centralized monitoring. A speaker and educator, Artem has presented at numerous global conferences, and co-authored the definitive guide to RBQM for clinical researchers. His company’s training arm, MyRBQM Academy, has educated over 1500 professionals from 400+ organizations, setting the standard for RBQM implementation worldwide. Whether modelling risk or mentoring the next generation of trial leaders, Artem is reshaping how the industry thinks about quality, reliability, and patient safety.

There are no comments yet.

Please log in to write the first comment.